C07C53/02

FORMIC ACID PRODUCTION METHOD AND FORMIC ACID PRODUCTION SYSTEM

The purpose of the present invention is to provide a formic acid production method and a formic acid production system with high production efficiency and in low cost. It is a formic acid production method comprising: preparing a mixed solution by mixing a solution containing an organic substance with a metal oxide powder having a photocatalyst function; and producing a formic acid by irradiating a light to the mixed solution. Also, it is a formic acid production system comprising: a raw material charging unit into which a solution containing an organic substance and a metal oxide powder having a photocatalyst function are charged; an artificial photosynthesis reaction unit for reacting a mixed solution of the organic substance and the metal oxide powder by irradiating a sunlight or a light to the mixed solution; and a formic acid recovery unit for recovering a formic acid from the mixed solution after an artificial photosynthesis reaction.

FORMIC ACID PRODUCTION METHOD AND FORMIC ACID PRODUCTION SYSTEM

The purpose of the present invention is to provide a formic acid production method and a formic acid production system with high production efficiency and in low cost. It is a formic acid production method comprising: preparing a mixed solution by mixing a solution containing an organic substance with a metal oxide powder having a photocatalyst function; and producing a formic acid by irradiating a light to the mixed solution. Also, it is a formic acid production system comprising: a raw material charging unit into which a solution containing an organic substance and a metal oxide powder having a photocatalyst function are charged; an artificial photosynthesis reaction unit for reacting a mixed solution of the organic substance and the metal oxide powder by irradiating a sunlight or a light to the mixed solution; and a formic acid recovery unit for recovering a formic acid from the mixed solution after an artificial photosynthesis reaction.

PLASMA CONVERSION REACTOR OF C02 WITH C1 TO C4 HYDROCARBON TO C1 TO C5 OXYGENATE AND METHOD THEREOF
20230234017 · 2023-07-27 ·

An apparatus for forming a C1 to C5 oxygenate from carbon dioxide and a C1 to C4 hydrocarbon is described. The apparatus comprises: a dielectric barrier discharge, DBD, device arranged to generate a plasma; and a passageway having an inlet for the carbon dioxide and the C1 to C4 hydrocarbon and an outlet for the oxygenates. In one example the passageway includes therein a catalyst. The passageway extends, at least in part, through the DBD device wherein, in use, the carbon dioxide in reacted with the C1 to C4 hydrocarbon in the generated plasma, thereby forming the oxygenates from at least some of the carbon dioxide and the C1 to C4 hydrocarbon. The DBD device comprises a conducting liquid as a ground electrode. A method and a use are also described.

PLASMA CONVERSION REACTOR OF C02 WITH C1 TO C4 HYDROCARBON TO C1 TO C5 OXYGENATE AND METHOD THEREOF
20230234017 · 2023-07-27 ·

An apparatus for forming a C1 to C5 oxygenate from carbon dioxide and a C1 to C4 hydrocarbon is described. The apparatus comprises: a dielectric barrier discharge, DBD, device arranged to generate a plasma; and a passageway having an inlet for the carbon dioxide and the C1 to C4 hydrocarbon and an outlet for the oxygenates. In one example the passageway includes therein a catalyst. The passageway extends, at least in part, through the DBD device wherein, in use, the carbon dioxide in reacted with the C1 to C4 hydrocarbon in the generated plasma, thereby forming the oxygenates from at least some of the carbon dioxide and the C1 to C4 hydrocarbon. The DBD device comprises a conducting liquid as a ground electrode. A method and a use are also described.

ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
20230001398 · 2023-01-05 · ·

Disclosed herein is a method for selectively reducing, using electrical energy, CO.sub.2 to carbon monoxide or formic acid, a catalyst for use in the method, and an electrochemical reduction system. The method for producing carbon monoxide or formic acid by electrochemically reducing carbon dioxide of the present invention includes (a) reacting carbon dioxide with a metal complex represented by formula (1), and (b) applying a voltage to a reaction product of the carbon dioxide and the metal complex represented by formula (1):

##STR00001##

ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE
20230001398 · 2023-01-05 · ·

Disclosed herein is a method for selectively reducing, using electrical energy, CO.sub.2 to carbon monoxide or formic acid, a catalyst for use in the method, and an electrochemical reduction system. The method for producing carbon monoxide or formic acid by electrochemically reducing carbon dioxide of the present invention includes (a) reacting carbon dioxide with a metal complex represented by formula (1), and (b) applying a voltage to a reaction product of the carbon dioxide and the metal complex represented by formula (1):

##STR00001##

MONONUCLEAR TRANSITION METAL COMPLEXES AND PHOTOCATALYSTS FOR CARBON DIOXIDE REDUCTION INCLUDING THE SAME
20220370995 · 2022-11-24 · ·

The present application provides a mononuclear transition metal complex, a photocatalyst for carbon dioxide reduction including same, and a method for reducing carbon dioxide to formic acid, the method comprising using the photocatalyst for carbon dioxide reduction.

MONONUCLEAR TRANSITION METAL COMPLEXES AND PHOTOCATALYSTS FOR CARBON DIOXIDE REDUCTION INCLUDING THE SAME
20220370995 · 2022-11-24 · ·

The present application provides a mononuclear transition metal complex, a photocatalyst for carbon dioxide reduction including same, and a method for reducing carbon dioxide to formic acid, the method comprising using the photocatalyst for carbon dioxide reduction.

ErbB/BTK inhibitors

Disclosed are compounds inhibiting ErbBs (e.g., EGFR or Her 2), especially mutant forms of ErbBs, and BTK, pharmaceutically acceptable salts, hydrates, solvates or stereoisomers thereof and pharmaceutical compositions comprising the compounds. The compound and the pharmaceutical composition can effectively treat ErbBs (especially mutant forms of ErbBs) or BTK associated diseases, including cancer.

Heterogeneous catalyst complex for carbon dioxide conversion

Proposed is a catalyst complex having high activity for carbon dioxide conversion reaction that converts carbon dioxide to useful compounds through reaction of carbon dioxide and hydrocarbon containing at least one hydroxyl group, and a carbon dioxide conversion process using the same, wherein the catalyst complex includes, as an active metal in the catalyst complex, at least one of noble metals and at least one of transition metals other than noble metals, thereby having high activity for the carbon dioxide conversion reaction.